Skip to main content
SpringerLink
Log in

Serotonin-induced platelet aggregation predicts the antihypertensive response to serotonin receptor antagonists

  • Originals
  • Published:
European Journal of Clinical Pharmacology Aims and scope Submit manuscript

Summary

The 5-HT2-receptor antagonist ketanserin (20–40 mg b.i.d.) was administered to 62 patients of both sexes with uncomplicated primary hypertension. After 4 weeks of treatment about 50% of the patients had reached the target diastolic blood pressure of 90 mm Hg or below. Interindividual variability was large. In a retrospective analysis the variability could not be explained by sex or the dose of ketanserin. There was a weak association between age and systolic blood pressure response (r=0,24; P=0.06), which could be entirely accounted for by the higher base line blood pressure in the elderly patients.

In one group of patients (n=12), the ex vivo aggregation to serotonin (10−6 M) was studied during treatment with placebo and ketanserin. Ketanserin completely inhibited 5-HT-induced aggregation in all patients. There was a close correlation between the area under the 5-HT-induced platelet aggregation curve during placebo and the subsequent reduction in diastolic blood pressure after 4 weeks of treatment with ketanserin.

The present data suggest that the blood pressure response to ketanserin can be predicted from the ex vivo sensitivity of platelets to serotonin. By implication, they also support a role for serotonergic mechanisms in hypertension.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Poplawski A, Skorulska M, Micwiarowski S (1968) Increased platelet adhesiveness in hypertensive cardiovascular disease. J Atheroscler Res 8: 721–723

    Google Scholar 

  2. Cocceri S, Fiorentini P (1971) Platelet adhesiveness and aggregation in hypertensive patients. Acta Med Scand Suppl 525: 273–275

    Google Scholar 

  3. Mehta J, Mehta P (1981) Platelet function in hypertension and effect of therapy. Am J Cardiol 47: 331–334

    Google Scholar 

  4. Kjeldsen SE, Gjesdal K, Eide I, Aakesson I, Amundsen R, Foss OP, Leren P (1983) Increased beta-thromboglobulin in essential hypertension; interactions between arterial plasma adrenaline, platelet function and blood lipids. Acta Med Scand 214: 369–373

    Google Scholar 

  5. Fetkovska N, Amstein R, Ferracin F, Regenass M, Buhler FR, Pletscher A (1990) 5-Hydroxytryptamine kinetics and activation of blood platelets in patients with essential hypertension. Hypertension 15: 267–273

    Google Scholar 

  6. De Clerck F, Van Neuten JM, Reneman RS (1984) Platelet vessel wall interactions: Implications of 5-hydroxytryptamine. A review. Agents and Actions 15: 612–626

    Google Scholar 

  7. Vanhoutte PM (1991) Platelet-derived serotonin, the endothelium and cardiovascular disease J Cradiovasc Pharmacol 17 [Suppl 5]: S6-S12

    Google Scholar 

  8. Van Nueten JM, Janssens WJ (1986) Augmentation of vasoconstrictor responses to by acute and chronic factors: inhibition by ketanserin. J Hypertens 4 [Suppl 1]: S55-S59

    Google Scholar 

  9. Doyle AE, Fraser JRE, Marshall RJ (1959) Reactivity of forearm vessels to vasoconstrictor substances in hypertensive and normotensive subjects. Clin Sci 18: 441–454

    Google Scholar 

  10. Webb RC, Vanhoutte PM (1985) Responsiveness of the hypertensive blood vessel wall to serotonergic stimuli. In: Vanhoutte PM (ed) Serotonin and the cardiovascular system. Raven Press, New York; pp 113–121

    Google Scholar 

  11. DeClerck F, David J-L, Janssen PAJ (1982) Inhibition of 5-hydroxytryptamine-induced and amplified platelet aggregation by ketanserin (R 41468), a selective 5-HT2-receptor antagonist. Agents Actions 12: 388–397

    Google Scholar 

  12. Hedner T, Persson B, Berglund G (1984) Ketanserin, a novel 5-hydrosytryptamine antagonist; monotherapy in essential hypertension. Br J Clin Pharmacol 16: 121–125

    Google Scholar 

  13. Persson B, Pettersson A, Hedner T (1987) Pharmacokinetics of ketanserin in patients with essential hypertension. Eur J Clin Pharmacol 32: 259–265

    Google Scholar 

  14. Hedner T, Pettersson A, Persson B (1987) Chronic 5-HT2 receptor blockade by ritanserin does not reduce the blood pressure in patients with essential hypertension. Acta Med Scand 222: 307–310

    Google Scholar 

  15. Nyberg G (1977) Indirect blood pressure and heart rate measured quickly without observer bias using a semiautomatic machine (Auto-Manometer) — response to isometric exercise in normally healthy males and its modification by b-receptor blockade. Br J Clin Pharmacol 4: 275–281

    Google Scholar 

  16. Winther K, Knudsen JB, Gormsen J, Jensen J (1986) Effect of metoprolol and propranolol on platelet aggregation and cAMP level in hypertensive patients. Eur J Clin Pharmacol 29: 1561–1564

    Google Scholar 

  17. Born GVR (1962) Aggregation of blood platelets by adenosine diphosphate and its reversal. Nature 194: 1927–1929

    Google Scholar 

  18. Brunner HR, Menard J, Waeber B, Burnier M, Brollaz J, Nussberger J, Belet M (1990) Treating the individual antihypertensive patient: considerations on dose, sequential monotherapy and drug combinations. J Hypertens 8: 3–13

    Google Scholar 

  19. Doyle AE (1991) Age-related effects of 5-HT2 antagonists. J Cardiovasc Pharmacol 17 [Suppl 5]: S29-S34

    Google Scholar 

  20. Persson B, Heykants J, Hedner T (1991) Clinical pharmacokinetics of ketanserin. Clin Pharmacokin 20: 263–279

    Google Scholar 

  21. DeCree J, Hoing M, de Ryck M, Symoens J (1985) The acute antihypertensive effect of ketanserin increases with age. J Cardiovasc Pharmacol 7 [Suppl 7]: S126-S127

    Google Scholar 

  22. Cameron HA, Ramsay LE (1985) Ketanserin and essential hypertension; a double-blind, placebo-controlled study. Postgrad Med J 61: 583–586

    Google Scholar 

  23. Beretta-Piccoli C, Amstein R, Bertel O, Brunner HR (1987) Antihypertensive efficacy of ketanserin alone or in combination with a β-blocker or diuretic. J Cardiovasc Pharmacol 10 [Suppl 2]: S107-S112

    Google Scholar 

  24. Breckenridge A (1988) Ageing, serotonin and ketanserin. Drugs 36 [Suppl 1]: 44–54

    Google Scholar 

  25. Elliot HL (1988) α1-adrenoceptor responsiveness: influence of age. J Cardiovasc Pharmacol 12 [Suppl 8]: S116-S120

    Google Scholar 

  26. Murray GD, Lesaffre E (1988) Statistical pitfalls in the analysis of age-related effects in antihypertensive therapy. J Cardiovasc Pharmacol 12 [Suppl 8]: S167-S172

    Google Scholar 

  27. Rosendorff C, Murray GD (1986) Ketanserin versus metoprolol and hydrochlorothiazide (HCTZ) in essential hypertension: only ketanserin's hypotensive effect is age-related. J Hypertens 4 [Suppl 6]: S109-S111

    Google Scholar 

  28. De Crée J, Leempoels J, Demoen B, Roels V, Verhagen H (1985) The effect of ketanserin, a 5-HT2-receptor antagonist, on 5-hydroxytryptamine-induced irreversible platelet aggregation in patients with cardiovascular disease. Agents Actions 16: 313–317

    Google Scholar 

  29. Mills DCB, Mac Farlene DE (1976) Platelet receptors. In: Gordan JL (ed) Platelets in biology and pathology. Biomedical Press, Amsterdam; pp 159–202

    Google Scholar 

  30. Amstein R, Fetkovska N, Pletscher A, Bühler FR (1989) Platelet deactivation by 5-HT2-receptor blockade parallells the antihypertensive response to ketanserin. J Hypertens 7: 255–260

    Google Scholar 

  31. Fetkovska N, Amstein R, Ferracini R, Regenass M, Buhler FR, Pletscher A (1985) 5-HT kinetics and sensitivity of human blood platelets: variations with age, gender and platelet number. Thromb Haemost 60: 486–490

    Google Scholar 

  32. Gleerup G, Winther K (1988) The effect of ageing on human platelet sensitivity to serotonin. Eur J Clin Invest 18: 504–506

    Google Scholar 

  33. Vanhoutte PM, Amery A, Birkenhäger W, Breckenridge A, Bühler F, Distler A, Dormandy J, Doyle A, Frohlich E, Hansson L (1988) Serotonergic mechanisms in hypertension: focus on the effects of ketanserin. Hypertension 11: 111–133

    Google Scholar 

  34. Gradin K, Pettersson A, Hedner T, Persson B (1985) Chronic 5-HT2-receptor blockade with ritanserin does not reduce the blood pressure in the spontaneously hypertensive rat. J Neural Transm 64: 145–149

    Google Scholar 

  35. Pettersson A, Gradin K, Hedner T, Persson B (1985) Antihypertensive mechanisms of action of ketanserin and some ketanserin analogues in the spontaneously hypertensive rat. Naunyn Schmiedeberg's Arch Pharmacol 329: 394–397

    Google Scholar 

  36. Reimann IW, Frölich JC (1983) Mechanism of the antihypertensive action of ketanserin in man. BMJ 287: 381–383

    Google Scholar 

  37. Wenting GJ, Brouwer RML, Meiracker v.d. AJ, Man int't Veld AJ, Schalekamp MADH (1987) Mechanism of action of ketanserin in hypertension and vasospastic disease. Acta Cardiolog 42: 339–354

    Google Scholar 

  38. Gradin K, Pettersson A, Hedner T, Persson B (1985) Antihypertensive effects of ketanserin in the spontaneously hypertensive rat: mode of action. J Cardiovasc Pharmacol 7 [Suppl 7]: S110-S111

    Google Scholar 

  39. Van der Starre PJA, Reneman RS (1988) The α-adrenergic receptor blocking effect of ketanserin and the interaction between α-adrenergic and S2-serotonergic blockade. J Cardiovasc Pharmacol 11 [Suppl 1]: S54-S61

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Medicine, Glostrup Hospital, Copenhagen, Denmark

    G. Gleerup

  2. Department of Clinical Chemistry, Glostrup Hospital, Copenhagen, Denmark

    K. Winther

  3. Department of Medicine, Sahlgren's Hospital, Gothenburg, Sweden

    B. Persson

  4. Department of Clinical Pharmacology, Sahlgren's Hospital, Gothenburg, Sweden

    T. Hedner

Authors
  1. G. Gleerup
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. B. Persson
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. T. Hedner
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. K. Winther
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Gleerup, G., Persson, B., Hedner, T. et al. Serotonin-induced platelet aggregation predicts the antihypertensive response to serotonin receptor antagonists. Eur J Clin Pharmacol 44, 121–125 (1993). https://doi.org/10.1007/BF00315468

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00315468

Key words

Search

Navigation